EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis

Dragana Savic iD, Teresa Bernadette Steinbichler, Julia Ingruber, Giulia Negro, Bertram Aschenbrenner, Herbert Riechelmann, Ute Ganswindt, Sergej Skvortsov, József Dudás iD, Ira-Ida Skvortsova iD

Cells · 16.01.2023 · 12 (2) · 336

DOI: 10.3390/cells12020336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 16.01.2023. Verfasst von Dragana Savic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Experimental and Translational Research on Radiation Oncology (EXTRO-Lab), Department of Therapeutic Radiology and Oncology, Medical U…. Hauptthemen laut MEDLINE: Ferroptosis, Head and Neck Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Anniversary Fund of the Austrian National Bank, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising pathway possessing druggable targets, such as xCT (SLC7A11). Unfortunately, little is known about the molecular mechanisms underlying the susceptibility of HNSCC cells to ferroptosis. The goal of this study was to determine whether HNSCC cells with activated Erk1/2 are vulnerable to ferroptosis induction. Our results have shown that xCT (SLC7A11) was overexpressed in malignant tissues obtained from the patients with HNSCC, whereas normal mucosa demonstrated weak expression of the protein. In order to investigate the role of Erk1/2 in the decrease in cell viability caused by erastin, xCT-overexpressing FaDu and SCC25 HNSCC cells were used. The ravoxertinib-dependent inhibition of Erk1/2 signaling led to the decrease in erastin efficacy due to the effect on ROS production and the upregulation of ROS scavengers SOD1 and SOD2, resulting in repressed lipid peroxidation. Therefore, it was concluded that the erastin-dependent activation of ferroptosis seems to be a promising approach which can be further developed as an additional strategy for the treatment of HNSCC. As ferroptosis induction via erastin is strongly dependent on the expression of Erk1/2, this MAP kinase can be considered as a predictor for cancer cells’ response to erastin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckReactive Oxygen SpeciesPiperazines

Stichwörter der Autor:innen

ERK signalingHNSCCerastinxCT

Substanzen

Reactive Oxygen SpecieserastinPiperazines

Autor:innen und Institutionen

  • Laboratory for Experimental and Translational Research on Radiation Oncology (EXTRO-Lab), Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
  • Tyrolean Cancer Research Institute (TKFI), A-6020 Innsbruck, Austria.
  • Department of Otorhinolaryngology and Head and Neck Surgery, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
  • University Hospital of Tyrol, A-6020 Innsbruck, Austria.
  • Department of Dermatology, Medical University of Vienna, A-1090 Vienna, Austria.
  • Department of Therapeutic Radiology and Oncology, A-6020 Innsbruck, Austria.

ORCID-Profile: Dragana Savic, József Dudás, Ira-Ida Skvortsova

Förderung

  • Austrian Science Fund FWF
  • Anniversary Fund of the Austrian National Bank
  • Austrian Science Fund
  • Ingrid Shaker-Nessmann Cancer Research Foundation

Zitieren

APA

Savic, D., Steinbichler, T. B., Ingruber, J., Negro, G., Aschenbrenner, B., Riechelmann, H., Ganswindt, U., Skvortsov, S., Dudás, J., & Skvortsova, I. I. (2023). Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis. Cells, 12(2), 336. https://doi.org/10.3390/cells12020336

Vancouver

Savic D, Steinbichler TB, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, et al. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis. Cells. 2023;12(2):336. doi:10.3390/cells12020336

BibTeX
@article{Savic2023,
  author = {Savic, Dragana and Steinbichler, Teresa Bernadette and Ingruber, Julia and Negro, Giulia and Aschenbrenner, Bertram and Riechelmann, Herbert and Ganswindt, Ute and Skvortsov, Sergej and Dudás, József and Skvortsova, Ira-Ida},
  title = {Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {2},
  pages = {336},
  doi = {10.3390/cells12020336}
}
Kostenlos starten →